Proposed Theranos CEO Ban Ups Ante For Lab Testing Cos.
By Sindhu Sundar (April 14, 2016, 10:48 PM EDT) -- An unusual proposal by the Centers for Medicare and Medicaid Services to impose a two-year ban on the high-profile CEO of Theranos over testing practices at one of its facilities is an example of the agency's sharpened focus on newer laboratory technologies that haven't yet been evaluated by other regulators, attorneys say.
The proposed sanction is part of the CMS' ongoing response to what it has characterized as serious shortcomings with laboratory practices in Theranos' facility in Newark, California. In a March letter, part of which was published by The Wall Street Journal on Wednesday, to Theranos CEO Elizabeth Holmes, director...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!